Validation of Coronary Angiography-Derived Vessel Fractional Flow Reserve in Heart Transplant Patients with Suspected Graft Vasculopathy.

cardiac transplant related arteriopathy fractional flow reserve functional assessment

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
24 Sep 2021
Historique:
received: 27 07 2021
revised: 20 09 2021
accepted: 22 09 2021
entrez: 23 10 2021
pubmed: 24 10 2021
medline: 24 10 2021
Statut: epublish

Résumé

Cardiac transplant-related vasculopathy remains a leading cause of morbidity and mortality in heart transplant (HTx) recipients. Recently, coronary angiography-derived vessel fractional flow reserve (vFFR) has emerged as a new diagnostic computational tool to functionally evaluate the severity of coronary artery disease. Although vFFR estimates have been shown to perform well against invasive FFR in atherosclerotic coronary artery disease, data on the use of vFFR in heart transplant recipients suffering from cardiac transplant-related arteriopathy are lacking. The aim of the presented study was to validate coronary angiography-derived vessel fractional flow reserve to calculate fractional flow reserve in HTx patients with and without cardiac transplant-related vasculopathy. A prospective, single center study of HTx patients referred for annual check-up, undergoing surveillance coronarography was conducted. Invasive FFR was measured using a motorized device at the speed of 1.0 mm/s in all three major coronary arteries. Angiography-derived pullback FFR was derived from the angiogram and compared with invasive FFR pullback curve. Overall, 18,059 FFR values were extracted from the FFR pullback curves from 23 HTx patients. The mean age was 59.3 ± 9.7 years, the mean time after transplantation was 5.24 years [IQR 1.20, 11.25]. A total of 39 vessels from 23 patients (24 LAD, 11 LCX, 4 RCA) were analyzed. Mean distal vFFR was 0.87 ± 0.14 whereas invasive distal FFR was 0.88 ± 0.17. An excellent correlation was found between invasive distal FFR and vFFR (r = 0.92;

Identifiants

pubmed: 34679451
pii: diagnostics11101750
doi: 10.3390/diagnostics11101750
pmc: PMC8534544
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
J Interv Cardiol. 2020 Jul 12;2020:9835151
pubmed: 32733172
J Heart Lung Transplant. 2017 Oct;36(10):1037-1046
pubmed: 28779893
J Am Coll Cardiol. 2005 May 3;45(9):1538-42
pubmed: 15862431
Am J Cardiol. 2007 Jun 1;99(11):1603-7
pubmed: 17531589
EuroIntervention. 2020 Sep 18;16(7):591-599
pubmed: 31085504
J Am Coll Cardiol. 2016 Aug 16;68(7):742-53
pubmed: 27515335
J Heart Lung Transplant. 2006 Jul;25(7):765-71
pubmed: 16818118
Circulation. 2003 Sep 30;108(13):1605-10
pubmed: 12963639
J Am Coll Cardiol. 2016 Jul 5;68(1):80-91
pubmed: 27364054
J Heart Lung Transplant. 2010 Jul;29(7):717-27
pubmed: 20620917
J Heart Lung Transplant. 2011 Oct;30(10):1078-94
pubmed: 21962016
JACC Basic Transl Sci. 2017 Aug 28;2(4):434-446
pubmed: 28920099
Circulation. 2016 May 17;133(20):1945-50
pubmed: 27143679

Auteurs

Niya Mileva (N)

Cardiovascular Center Aalst, OLV Clinic, 9300 Aalst, Belgium.
Cardiology Clinic, Alexandrovska University Hospital, 1430 Sofia, Bulgaria.

Sakura Nagumo (S)

Cardiovascular Center Aalst, OLV Clinic, 9300 Aalst, Belgium.
Department of Cardiology, Showa University Fujigaoka Hospital, Tokyo 8501, Japan.

Emanuele Gallinoro (E)

Cardiovascular Center Aalst, OLV Clinic, 9300 Aalst, Belgium.
Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", 81100 Naples, Italy.

Jeroen Sonck (J)

Cardiovascular Center Aalst, OLV Clinic, 9300 Aalst, Belgium.
Department of Advanced Biomedical Sciences, University Federico II, 80131 Naples, Italy.

Sofie Verstreken (S)

Cardiovascular Center Aalst, OLV Clinic, 9300 Aalst, Belgium.

Riet Dierkcx (R)

Cardiovascular Center Aalst, OLV Clinic, 9300 Aalst, Belgium.

Ward Heggermont (W)

Cardiovascular Center Aalst, OLV Clinic, 9300 Aalst, Belgium.

Jozef Bartunek (J)

Cardiovascular Center Aalst, OLV Clinic, 9300 Aalst, Belgium.

Marc Goethals (M)

Cardiovascular Center Aalst, OLV Clinic, 9300 Aalst, Belgium.

Alex Heyse (A)

Cardiovascular Center Aalst, OLV Clinic, 9300 Aalst, Belgium.

Emanuele Barbato (E)

Cardiovascular Center Aalst, OLV Clinic, 9300 Aalst, Belgium.
Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", 81100 Naples, Italy.

Bernard De Bruyne (B)

Cardiovascular Center Aalst, OLV Clinic, 9300 Aalst, Belgium.
Department of Cardiology, Lausanne University Hospital, 1100 Lausanne, Switzerland.

Carlos Collet (C)

Cardiovascular Center Aalst, OLV Clinic, 9300 Aalst, Belgium.

Marc Vanderheyden (M)

Cardiovascular Center Aalst, OLV Clinic, 9300 Aalst, Belgium.

Classifications MeSH